New York, New York 10065


The purpose of this study is to develop a screening tool to help identify family members who may need professional emotional support. The investigators are interested in enrolling family members of patients with advanced cancer care as well as family members who have lost a loved one to cancer. Some screening tools to identify family members who might need support do exist, but the investigators are hoping to develop one that is brief and easier for healthcare providers to use. The information learned in this study will help us refine the screening tool. The investigators are interviewing family members to identify which questions or items work well, which seem unclear, and to understand how a family member might approach completing the screening tool. Family member input will be essential in the development of this screening tool.


Inclusion Criteria: - As per self-report, 21 years or older - As per self-report, has a domestic partner or spouse, child (minor or adult), sibling (sister or brother), or parent diagnosed with an advanced cancer diagnosis OR As per self-report, experienced the recent (within 2 months to 3 year) cancer-related death of a domestic partner or spouse, child (minor or adult), sibling, or parent - Responds "yes" to the question "Can you understand spoken and written English? - Agrees to be audio-taped during the cognitive interview [Waves 1 and 2 only] * For Part 2 only: In the event that the patient dies prior to a consenting pre-loss family member completing the study questionnaires, the family member will be eligible for participation in the post-loss group after at least 2 months have passed after the loss Exclusion Criteria: - Significant psychiatric or cognitive disturbance sufficient, in the investigators' judgment, to preclude the completion of the assessment measures or informed consent (i.e., acute psychiatric or neurological symptoms which require individual treatment) - Another family member (parent, domestic partner or spouse, sibling, or adult child) has been enrolled in the study



Primary Contact:

Principal Investigator
Wendy Lichtenthal, PhD
Memorial Sloan Kettering Cancer Center

Wendy Lichtenthal, PhD
Phone: 646-888-4812

Backup Contact:

Stacy Stabler, MD
Phone: 646-888-3194

Location Contact:

New York, New York 10065
United States

Wendy Lichtenthal, Ph.D.
Phone: 646-888-4812

Site Status: Recruiting

Data Source:

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.